Page last updated: 2024-08-21

cupric sulfide and Anoxemia

cupric sulfide has been researched along with Anoxemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, Z; Li, J; Liao, N; Liu, G; Liu, J; Liu, X; Wei, Z; Wu, L; Wu, M; Yang, H; Zhang, D; Zhang, X; Zheng, A	1

Other Studies

1 other study(ies) available for cupric sulfide and Anoxemia

Article	Year
Smart Cu(II)-aptamer complexes based gold nanoplatform for tumor micro-environment triggered programmable intracellular prodrug release, photodynamic treatment and aggregation induced photothermal therapy of hepatocellular carcinoma. Theranostics, 2017, Volume: 7, Issue:1 Topics: Animals; Anthraquinones; Antineoplastic Agents; Aptamers, Nucleotide; Carcinoma, Hepatocellular; Copper; Disease Models, Animal; Drug Carriers; Gold; Hep G2 Cells; Heterografts; Humans; Hyperthermia, Induced; Hypoxia; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Photochemotherapy; Prodrugs; Treatment Outcome	2017

Article

Year

Smart Cu(II)-aptamer complexes based gold nanoplatform for tumor micro-environment triggered programmable intracellular prodrug release, photodynamic treatment and aggregation induced photothermal therapy of hepatocellular carcinoma.

Theranostics, 2017, Volume: 7, Issue:1

Topics: Animals; Anthraquinones; Antineoplastic Agents; Aptamers, Nucleotide; Carcinoma, Hepatocellular; Copper; Disease Models, Animal; Drug Carriers; Gold; Hep G2 Cells; Heterografts; Humans; Hyperthermia, Induced; Hypoxia; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Photochemotherapy; Prodrugs; Treatment Outcome

2017